Maitake Research

Anti-diabetic activity present in the fruit body of Grifola frondosa (Maitake).

 

Kubo K, Aoki H, Nanba H

Yukiguni Maitake Co., Ltd. Niigata, Japan.

The fruit body of Grifola frondosa (maitake), Basidiomycetes was confirmed to contain
substances with anti-diabetic activity. When 1 g/d of powdered fruit body of maitake was given
orally to a genetically diabetic mouse (KK-Ay), blood glucose reduction was observed, in
contrast to the control group in which the blood glucose increased with ageing. Moreover, levels
of insulin and triglyceride in plasma demonstrated a change similar to blood glucose with feeding
of maitake. Ether-ethanol-soluble (ES) and hot water-soluble (WS) fractions were prepared
from the fruit body and their hypoglycemic activity was examined. Blood glucose-lowering
activity was found when ES-fraction or WS-50% ethanol float (X) fraction was administered
orally, but other WS-fractions were inactive. These results suggest that the anti-diabetic activity
was present not only in the ES-fraction consisting of lipid but also in the X-fraction of
peptidoglycan (sugar:protein = 65:35).


Table of Contents

 

Bookmark and Share

Bookmark this page into your favorite bookmark manager. Or press (CTRL-D)


NOTE: Regardless of how our products are used in other countries, or anything that you may have heard or read, under FDA law in the United States, it is illegal for a manufacturer to make any medical claims for health supplements. None of the products offered for sale on this website have been evaluated by the FDA. All statements made by Aloha Medicinals Inc. are intended for informational purposes only. Our products are not intended to diagnose, treat, cure or prevent any disease. Health decisions are much too important to be made without the advice of a health care practitioner. We invite and encourage you to share this information with your doctor. We are happy to share our research materials with anyone who asks.